What Are the Tests They Do During Pregnancy: A Complete Guide to Prenatal Screening and Diagnostics

From the moment you see those two lines on a test, your world shifts, filled with a potent mix of joy, anticipation, and a thousand new questions. Chief among them for many is a simple yet profound query: Is my baby okay? Modern prenatal care offers a powerful lens to peer into the womb, providing answers and reassurance through a carefully orchestrated series of tests and screenings designed to monitor your health and your baby's development from conception to delivery. This journey through prenatal testing is a cornerstone of a healthy pregnancy, empowering you with information and preparing you for the arrival of your little one.

The First Trimester: Confirmation and Early Screening

The initial weeks of pregnancy are a whirlwind of change, both emotionally and physically. Prenatal care begins with tests to confirm the pregnancy and establish a baseline for your health and the baby's viability.

Initial Confirmatory and Routine Tests

The very first tests are often a urine test to detect the pregnancy hormone hCG and a blood test for the same hormone, which can provide a more quantitative measurement. Your first prenatal appointment will typically include a comprehensive set of assessments:

Blood Type and Rh Factor: Determining your blood type (A, B, AB, or O) and whether you are Rh-positive or Rh-negative is critical. If an Rh-negative mother carries an Rh-positive baby, it can lead to complications without proper management.
Complete Blood Count (CBC): This common test checks for anemia (low red blood cell count), which is common in pregnancy and can cause fatigue, and assesses your white blood cell and platelet counts.
Immunity and Infection Screening: A battery of tests checks for immunity to certain diseases and screens for infections that could affect the fetus. This includes Rubella (German measles) immunity, Hepatitis B and C, Syphilis, and HIV. Early detection allows for interventions to protect both you and the baby.
Urinalysis and Urine Culture: A simple urine test checks for signs of a urinary tract infection, which are common and often asymptomatic in pregnancy but can lead to complications if untreated. It also screens for protein, which can be a sign of preeclampsia later on, and glucose, which may indicate a risk for gestational diabetes.
Pap Smear: Often performed at the first visit if you are due for one, to check for cervical abnormalities.
Carrier Screening for Genetic Conditions: This is an optional blood or saliva test that can be done before or during pregnancy to see if you or your partner carry genes for certain inherited conditions, such as Cystic Fibrosis, Spinal Muscular Atrophy, Tay-Sachs disease, or sickle cell anemia. If both parents are carriers, there is a risk the child could have the condition.

First-Trimester Combined Screening

Around weeks 10 to 13 of pregnancy, you will be offered an optional screening to assess the risk of certain chromosomal abnormalities, notably Down syndrome (trisomy 21) and Edwards syndrome (trisomy 18). This non-invasive test involves two parts:

Blood Test: Measures the levels of two pregnancy-associated proteins: Pregnancy-Associated Plasma Protein-A (PAPP-A) and human Chorionic Gonadotropin (hCG). Unusual levels can indicate a higher risk.
Nuchal Translucency (NT) Ultrasound: A specialized ultrasound measures the clear (translucent) space in the tissue at the back of the baby's neck. Fluid accumulation here can be associated with an increased risk of chromosomal abnormalities.

The results of the blood test and the NT measurement, combined with the mother's age, are used to calculate a probability score for the conditions. It is crucial to remember this is a screening test, not a diagnostic one; it estimates risk but does not provide a definitive yes or no answer.

Non-Invasive Prenatal Testing (NIPT)

This is a more advanced, highly accurate screening option, also known as cell-free DNA testing. It involves a simple blood draw from the mother, usually after 10 weeks. The test analyzes tiny fragments of the baby's DNA that are circulating in the mother's bloodstream. It can screen for chromosomal abnormalities like Down syndrome, Edwards syndrome, and Patau syndrome (trisomy 13) with a very high degree of accuracy (over 99% for some conditions). It can also detect fetal sex and screen for abnormalities in sex chromosomes. Like the combined screening, NIPT is a screening test, not a diagnostic one, though its false positive rate is very low.

The Second Trimester: Detailed Anatomy and Further Screening

As the pregnancy progresses into the second trimester, the focus of testing shifts toward a detailed assessment of the baby's growth and anatomy, alongside broader maternal health screenings.

The Anatomy Scan (Level II Ultrasound)

Performed between weeks 18 and 22, this is often the most anticipated test for expectant parents. This detailed ultrasound examination lasts about 30-45 minutes and is a thorough check of the baby's development. The sonographer will methodically examine:

Brain, Face, and Skull: Checking for proper structure and development.
Heart: Looking at the four chambers, valves, and major vessels to screen for congenital heart defects.
Spine: Ensuring the vertebrae are aligned and skin-covered.
Stomach, Kidneys, and Bladder: Confirming the presence and normal appearance of abdominal organs.
Limbs: Measuring bones and counting fingers and toes.
Placenta: Assessing its location, size, and appearance.
Amniotic Fluid Levels: Ensuring there is an adequate amount.
Umbilical Cord: Checking that it has three vessels.

This scan can also often reveal the baby's sex, if parents wish to know. It provides immense reassurance by visualizing the intricate details of the growing fetus.

Second-Trimester Maternal Serum Screening (The "Quad Screen")

If first-trimester screening was not performed, a quad screen is offered between weeks 15 and 22. This blood test measures the levels of four substances produced by the placenta and the fetus: Alpha-fetoprotein (AFP), Estriol, hCG, and Inhibin A. The pattern of these levels can help assess the risk of:

Neural Tube Defects: Such as spina bifida (an open spine) or anencephaly (an underdeveloped brain and skull), indicated by high AFP.
Chromosomal Abnormalities: Such as Down syndrome or Edwards syndrome, indicated by a particular pattern of all four markers.

Again, this is a screening test that provides a risk assessment, not a diagnosis.

Glucose Challenge Test (GCT) and Glucose Tolerance Test (GTT)

Between weeks 24 and 28, all pregnant women are screened for gestational diabetes, a type of diabetes that develops during pregnancy. The process usually involves:

Glucose Challenge Test (GCT): You drink a sweet glucose solution. After one hour, a blood sample is taken to measure your blood sugar level. If the level is elevated, it indicates a need for further testing.
Glucose Tolerance Test (GTT): If the GCT is failed, this longer, more definitive test is performed. After fasting, a baseline blood sugar level is checked. You then drink a higher-concentration glucose solution, and your blood is drawn every hour for two to three hours to see how your body processes the sugar over time.

A diagnosis of gestational diabetes requires careful management through diet, exercise, and sometimes medication to prevent complications for both mother and baby.

Diagnostic Tests: When More Information Is Needed

If a screening test returns a result indicating an increased risk, or if there are other concerning factors (like advanced maternal age or a family history of genetic disorders), diagnostic tests are offered. Unlike screenings, these tests can provide a definitive diagnosis but carry a small risk of pregnancy loss.

Chorionic Villus Sampling (CVS)

This test is typically performed between weeks 10 and 13. It involves collecting a tiny sample of tissue from the placenta, called chorionic villi, which share the baby's genetic makeup. The sample can be obtained either through the cervix (transcervical) or the abdomen (transabdominal), guided by ultrasound. The cells are then analyzed for chromosomal abnormalities and specific genetic disorders. CVS provides early diagnosis but carries a slightly higher risk of miscarriage than amniocentesis, approximately 1 in 500.

Amniocentesis (Amnio)

Usually performed between weeks 15 and 20, this procedure involves using a thin needle, guided by ultrasound, to extract a small amount of amniotic fluid from the sac surrounding the baby. This fluid contains fetal cells that are cultured and analyzed for chromosomal abnormalities, genetic problems, and neural tube defects (by measuring AFP levels in the fluid). The risk of miscarriage from an amniocentesis is very low, generally cited as about 1 in 900 to 1 in 1,000. It is considered the gold standard for prenatal diagnosis.

The Third Trimester: Preparing for Delivery

The final stretch of pregnancy involves tests to ensure both mother and baby remain healthy and to prepare for a safe delivery.

Group B Streptococcus (GBS) Screening

Between weeks 36 and 38, a swab is taken from the vagina and rectum to test for the presence of Group B Strep bacteria. GBS is common and typically harmless in healthy adults, but if passed to the baby during delivery, it can cause serious illness. If you test positive, you will receive intravenous antibiotics during labor to protect the baby.

Repeat Blood Tests

Your CBC is often repeated in the third trimester to check for anemia again. Your antibody screen is also repeated if you are Rh-negative.

Non-Stress Test (NST) and Biophysical Profile (BPP)

If a pregnancy is considered high-risk (due to conditions like hypertension, gestational diabetes, or going past the due date) or if there are concerns about the baby's movements, these tests may be performed weekly or even more frequently.

Non-Stress Test (NST): You lie down with two sensors on your abdomen—one to monitor the baby's heart rate and another to measure contractions. The test looks for accelerations in the fetal heart rate when the baby moves, which is a sign of good health and adequate oxygen supply.
Biophysical Profile (BPP): This combines a non-stress test with a detailed ultrasound to score the baby on five factors: breathing movements, body movements, muscle tone, amniotic fluid volume, and the heart rate reactivity measured by the NST. Each category is given a score, and the total score helps assess whether the baby is doing well or may need to be delivered.

Kick Counts

While not a clinical test per se, in the third trimester, you will be encouraged to monitor your baby's movements daily. A consistent pattern of active periods is a good sign of fetal well-being. A noticeable decrease in movements warrants a call to your healthcare provider, who may then recommend an NST or BPP.

Navigating the world of prenatal testing can feel overwhelming, but each blood draw, each ultrasound, is a step on the path to meeting your baby. This incredible suite of medical tools offers a window into the secret world of pregnancy, providing crucial information that guides care, manages risks, and, most importantly, offers priceless peace of mind. It’s a journey of discovery, transforming the unknown into a detailed map that helps you confidently prepare for the life-changing adventure of parenthood that lies ahead.

volver al blog